How are thrombin inhibitors monitored during the treatment of hereditary and acquired hypercoagulability?

Updated: Jan 05, 2018
  • Author: Paul Schick, MD; Chief Editor: Srikanth Nagalla, MBBS, MS, FACP  more...
  • Print
Answer

The Ecarin clotting time (ECT), [49] activated clotting time, [50] and activated factor X tests have been used to monitor antithrombin agent therapy. The Ecarin clotting time is thought to be the most reliable test, but further clinical experience with this assay would be important to establish a more complete track record. [49] Unfortunately, the Ecarin clotting time is not available at most medical centers.


Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!